Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study.

Jacob TønnesenJannik PallisgaardPeter Vibe Rasmussen Martin Huth RuwaldMorten LambertsNina NouhraveshJarl StrangeGunnar Hilmar GislasonMorten Lock Hansen

Published in: BMJ open (2023)

We found that most VTE events happen close to onset of the GI cancer diagnosis and thrombogenicity differed by type of GI cancer, ranging from 7.8% in patients with pancreatic cancer to 3.6% in colorectal and patients with liver cancer. Prior VTE, heart failure, COPD, liver disease, CKD and DM were associated with increased risk of VTE.

Keyphrases

venous thromboembolism
papillary thyroid
heart failure
squamous cell
direct oral anticoagulants
left ventricular
cross sectional
skeletal muscle
lung function
cystic fibrosis
acute heart failure